A new study recently published in JAMA Psychiatry found that a layperson-delivered phone call program could reduce feelings of loneliness, depression, and anxiety. These calls also improved the general mental health of study participants within 4 weeks. Each caller contacted…
Read More
UNH receives $2.97 million in grants to investigate the effectiveness of wilderness therapy
The University of New Hampshire’s Outdoor Behavioral Healthcare Center receives $2.97 million in grants to conduct a first-of-its-kind randomized study looking at the effectiveness of outdoor behavioral health (OBH), or wilderness therapy, a prescriptive treatment for teens struggling with depression,…
Read More
Rixadone Oral
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. RIXADONE Risperidone Oral solution 1mg/mL Consumer Medicine Information What is in this leaflet Please read this leaflet carefully before you start taking Rixadone. This leaflet answers some…
Read More
APOTEX-Pantoprazole
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APOTEX- PANTOPRAZOLE TABLETS Contains the active ingredient, pantoprazole (as sodium sesquihydrate) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about pantoprazole….
Read More
Buvidal Monthly
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BUVIDAL® Buprenorphine Consumer Medicine Information Warning: Risk of Serious Harm or Death with Intravenous Administration Serious harm or death could result if administered intravenously. Buvidal Monthly forms…
Read More
APO-Amisulpride
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-AMISULPRIDE Amisulpride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about amisulpride. It does not contain all the available information. It…
Read More
Midazolam Injection
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. MIDAZOLAM INJECTION Midazolam Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Midazolam Injection. It does not contain all the available…
Read More
Anafranil
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ANAFRANIL® clomipramine hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Anafranil. It does not contain all the available information….
Read More